{{ currentBoardShortName }}
  • Markets
  • Indices
  • FX
  • Energy
  • Metals
Markets
As of: {{timeStamp.date}}
{{timeStamp.time}}

Markets

{{ currentBoardShortName }}
  • Markets
  • Indices
  • FX
  • Energy
  • Metals
{{data.symbol | reutersRICLabelFormat:group.RICS}}
 
{{data.netChng | number: 4 }}
{{data.netChng | number: 2 }}
{{data | displayCurrencySymbol}} {{data.price | number: 4 }}
{{data.price | number: 2 }}
{{data.symbol | reutersRICLabelFormat:group.RICS}}
 
{{data.netChng | number: 4 }}
{{data.netChng | number: 2 }}
{{data | displayCurrencySymbol}} {{data.price | number: 4 }}
{{data.price | number: 2 }}
  • NEW FEATURE:

    BNN.CA NOW OFFERING REAL-TIME TSX STOCK QUOTES

Commodities Videos

VIDEO SIGN OUT

{{ currentStream.Name }}

{{ currentStream.Desc }}

Related Video

Continuous Play:
ON OFF

The information you requested is not available at this time, please check back again soon.

From aluminum to zinc and everything in between, join BNN for the latest insight into the hot world of commodities and the companies that produce them, including interviews with mineral and mining entrepreneurs from Canada and around the globe. Whether it's a gold play in the Andes or a hot offshore oil prospect, BNN has you covered on commodities. 

 

Email: commodities@bnn.ca

Feb 23, 2017

Canopy vows clean up at Mettrum amid ‘inexcusable’ pesticide use on cannabis

Flowering marijuana plants at Canopy Growth's Tweed facility in Smiths Falls, Ont.

Security Not Found

The stock symbol {{StockChart.Ric}} does not exist

See Full Stock Page »

Canopy Growth Corporation's CEO is looking to assuage quality control fears less than a month after closing his company's takeover of Mettrum Health Corp.

Canopy CEO Bruce Linton said in an open letter released Thursday morning that steps are being taken "to enhance quality assurance practices and operational controls."

Canopy (WEED.TO), Canada's largest licensed medical cannabis producer, struck a $430-million all-stock takeover agreement with Mettrum in December, and the transaction subsequently closed at the end of January. The target company had announced a voluntary recall in November as a result of certain products being exposed to pesticides.

"The application of pest control products not registered for use on cannabis at Mettrum was inexcusable," Linton said in his open letter. "Mettrum has work to do to regain customer and physician confidence. I believe we have a team in place that is up to the challenge."

 

Canopy Growth CEO 'confident' Mettrum acquisition vote will pass

Mettrum shareholders will hold a vote on Canopy's acquisition offer. Bruce Linton, CEO of Canopy Growth, joins BNN for a closer look at how he thinks the result of the vote will turn out.